Abiraterone Acetate
- Product NDC
- 0093-1125
- 11-digit product format
- 000931125
- Labeler code
- 0093
- Product ID
- 0093-1125_81772086-cab1-4658-8132-d0650a06a4c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abiraterone Acetate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA208432
- Marketing category
- ANDA
- Marketing start
- 2018-11-21
- Marketing end
- 0000-00-00
- Substance
- ABIRATERONE ACETATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-1125-89 | 00093112589 | 120 TABLET, FILM COATED in 1 BOTTLE (0093-1125-89) | 2018-11-21 | 0000-00-00 | No | No | Current |